SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-277950
Filing Date
2023-11-15
Accepted
2023-11-15 16:50:02
Documents
12
Period of Report
2023-11-10
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K d850611d8k.htm   iXBRL 8-K 28816
  Complete submission text file 0001193125-23-277950.txt   151666

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA veru-20231110.xsd EX-101.SCH 2507
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20231110_lab.xml EX-101.LAB 17958
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20231110_pre.xml EX-101.PRE 11236
6 EXTRACTED XBRL INSTANCE DOCUMENT d850611d8k_htm.xml XML 3575
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 231411239
SIC: 2834 Pharmaceutical Preparations